BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28533666)

  • 1. Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors.
    Paiella S; Impellizzeri H; Zanolin E; Marchegiani G; Miotto M; Malpaga A; De Robertis R; D'Onofrio M; Rusev B; Capelli P; Cingarlini S; Butturini G; Davì MV; Amodio A; Bassi C; Scarpa A; Salvia R; Landoni L
    World J Gastroenterol; 2017 May; 23(17):3092-3098. PubMed ID: 28533666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery.
    Canellas R; Lo G; Bhowmik S; Ferrone C; Sahani D
    J Magn Reson Imaging; 2018 Feb; 47(2):425-432. PubMed ID: 28480609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of Radio-Guided Surgery with ⁶⁸Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors.
    Sadowski SM; Millo C; Neychev V; Aufforth R; Keutgen X; Glanville J; Alimchandani M; Nilubol N; Herscovitch P; Quezado M; Kebebew E
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S676-82. PubMed ID: 26350374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors.
    Keck KJ; Maxwell JE; Menda Y; Bellizzi A; Dillon J; O'Dorisio TM; Howe JR
    Surgery; 2017 Jan; 161(1):272-279. PubMed ID: 27863780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-tektrotyd SPECT/MRI in the diagnosis of a gastroenteropancreatic neuroendocrine tumor.
    Zandieh S; Gambini JP; Haller J; Rodrigues M
    Clin Nucl Med; 2012 Apr; 37(4):e84-5. PubMed ID: 22391730
    [No Abstract]   [Full Text] [Related]  

  • 6. A rare case with synchronous gastric gastrointestinal stromal tumor, pancreatic neuroendocrine tumor, and uterine leiomyoma.
    Arabadzhieva E; Yonkov A; Bonev S; Bulanov D; Taneva I; Vlahova A; Dikov T; Dimitrova V
    World J Surg Oncol; 2016 Nov; 14(1):287. PubMed ID: 27846844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic neuroendocrine tumor in a patient with a TSC1 variant: case report and review of the literature.
    Mortaji P; Morris KT; Samedi V; Eberhardt S; Ryan S
    Fam Cancer; 2018 Apr; 17(2):275-280. PubMed ID: 28887784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors.
    Hasegawa S; Kobayashi N; Tokuhisa M; Goto A; Takano S; Takada Y; Kaneta T; Mori R; Matsuyama R; Endo I; Yamanaka S; Nakajima A; Inoue T; Ichikawa Y
    Digestion; 2017; 96(1):13-20. PubMed ID: 28609761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
    Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
    Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary?
    Naswa N; Sharma P; Gupta SK; Karunanithi S; Reddy RM; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
    Clin Nucl Med; 2014 Jan; 39(1):e27-34. PubMed ID: 24217539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
    Li JK; Wang M; Yuan J; Song ZG
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
    [No Abstract]   [Full Text] [Related]  

  • 12. Diffuse Bone Metastases in Pancreatic Neuroendocrine Tumor Shown on Octreoscan.
    Adkins J; Lu Y
    Clin Nucl Med; 2019 Mar; 44(3):257-258. PubMed ID: 30624276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?
    Luo Y; Chen J; Huang K; Lin Y; Chen M; Xu L; Li ZP; Feng ST
    BMC Cancer; 2017 Feb; 17(1):154. PubMed ID: 28231773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of secretory tumors of the gastrointestinal tract.
    ElGuindy YM; Javadi S; Menias CO; Jensen CT; Elsamaloty H; Elsayes KM
    Abdom Radiol (NY); 2017 Apr; 42(4):1113-1131. PubMed ID: 27878636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice.
    van Beek DJ; Pieterman CRC; Wessels FJ; van de Ven AC; de Herder WW; Dekkers OM; Zandee WT; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    Front Endocrinol (Lausanne); 2022; 13():926491. PubMed ID: 36277719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
    Deppen SA; Liu E; Blume JD; Clanton J; Shi C; Jones-Jackson LB; Lakhani V; Baum RP; Berlin J; Smith GT; Graham M; Sandler MP; Delbeke D; Walker RC
    J Nucl Med; 2016 May; 57(5):708-14. PubMed ID: 26769865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is 18F-Fluorodeoxyglucose the Tracer of Choice for Functional Imaging of Neuroendocrine Tumors Grade 3? A Case Report.
    Lorusso M; Inzani F; Castaldi P; Menghi R; Schinzari G; Rindi G; Rufini V
    Pancreas; 2018 Apr; 47(4):e20-e22. PubMed ID: 29521949
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.
    Polenta V; Slater EP; Kann PH; Albers MB; Manoharan J; Ramaswamy A; Mahnken AH; Bartsch DK
    World J Surg; 2018 May; 42(5):1440-1447. PubMed ID: 29075857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroenteropancreatic neuroendocrine tumors: impact of consistent contrast agent selection on radiologists' confidence in hepatic lesion assessment on restaging MRIs.
    Balthazar P; Shinagare AB; Tirumani SH; Jagannathan JP; Ramaiya NH; Khorasani R
    Abdom Radiol (NY); 2018 Jun; 43(6):1386-1392. PubMed ID: 28840281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Size on Microscopy, CT, and MRI Assessments Versus Pathologic Gross Specimen Analysis of Pancreatic Neuroendocrine Tumors.
    Bian Y; Li J; Jiang H; Fang X; Cao K; Ma C; Lu J
    AJR Am J Roentgenol; 2021 Jul; 217(1):107-116. PubMed ID: 33978449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.